send mail to support@abhimanu.com mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
By Loging in you agree to Terms of Services and Privacy Policy
Claim your free MCQ
Please specify
Sorry for the inconvenience but we’re performing some maintenance at the moment. Website can be slow during this phase..
Please verify your mobile number
Login not allowed, Please logout from existing browser
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Your Free user account at abhipedia has been created.
Remember, success is a journey, not a destination. Stay motivated and keep moving forward!
Refer & Earn
Enquire Now
My Abhipedia Earning
Kindly Login to view your earning
Support
According to Chief Scientist of the World Health Organisation (WHO), Dr. Soumya Swaminathan, COVID-19 in India may be entering the stage of endemicity where low or moderate level of transmission will go on.
On the clearance of India’s homegrown COVID-19 vaccine ‘COVAXIN’, she was confident that the technical team of WHO will be satisfied to give clearance to be its authorized vaccines.
Chief Scientist noted that, due to size, heterogeneity of population and immunity status across the country, it is feasible that this situation in India may continue with ups and downs in various parts of India. India may be entering the stage of endemicity where moderate or low level of transmission will continue to happen however, no exponential growth or peaks will be there.
On the issue of prevalence of COVID-19 among children, she notes that, according to Sero Survey, it is possible that children can get infected and transmit. But they will be having mild illness most of the time. Very small percentage will get sick & inflammatory complications and few will die. But the number will be much less than the adult population.
On the topic of using drugs like HCQ, Remdesivir or Ivermectin, she notes that, as of now there are no evidence of role of Ivermectin or HCQ in reducing mortality or morbidity in people infected with the COVID-19 virus. These drugs also have no role in preventing the infection.
By: Brijesh Kumar ProfileResourcesReport error
Access to prime resources